OMRON Healthcare to Donate 3,000 Blood Pressure Monitors for May Measurement Month 2026

OMRON Healthcare Co., Ltd., a global leader in home health monitoring devices, announced its support for May Measurement Month 2026, an annual blood pressure screening campaign coinciding with World Hypertension Day on May 17. The company will donate approximately 3,000 blood pressure monitors worldwide, including models capable of detecting atrial fibrillation (AFib), to support screening and awareness activities across participating countries.

Hypertension remains the leading risk factor for cardiovascular disease globally, contributing to over 10 million deaths each year. Despite the availability of effective management strategies, awareness and treatment rates remain suboptimal in many regions. Since its launch in 2017, May Measurement Month has screened more than 7 million people, identifying over 1 million individuals with previously untreated hypertension. OMRON Healthcare has supported the campaign from its inception, donating about 33,000 blood pressure monitors to date across approximately 120 countries and regions.

This year's contribution of 3,000 devices includes models that can screen for AFib, a common yet underrecognized arrhythmia that often goes undiagnosed despite being a major risk factor for stroke and heart failure. The campaign, running from May to July, will feature screening events and educational activities worldwide, including blood pressure measurement sessions and guidance on lifestyle changes for hypertension management.

Professor Neil R. Poulter, Chief Investigator and Chair of Trustees of May Measurement Month, emphasized the importance of regular home blood pressure monitoring. “Hypertension is the leading risk factor for cardiovascular diseases, including stroke, heart attacks, heart failure, and atrial fibrillation. By donating blood pressure monitors capable of detecting probable atrial fibrillation, this initiative can enhance early detection and treatment, ultimately helping to save more lives around the world,” he said.

Ayumu Okada, President and CEO of OMRON Healthcare, noted the alignment of the campaign with the company's vision. “Since launching our first home blood pressure monitor in 1973, we have worked to promote the importance of blood pressure monitoring. The goals of May Measurement Month align closely with our Going for ZERO vision, which aims to eliminate cerebro-cardiovascular events worldwide. We will continue to collaborate to improve global cardiovascular health outcomes,” Okada stated.

The initiative underscores the critical role of early detection in reducing the burden of cardiovascular diseases. With hypertension often asymptomatic, regular monitoring and screening can identify at-risk individuals before complications arise. OMRON's donation of AFib-capable monitors adds a layer of screening for a condition that affects millions undiagnosed worldwide.

For more information about May Measurement Month, visit maymeasure.org.